Xiangrong Song

Co-Founder & CEO at WestGene Biopharma

Speaker

Dr. Xiangrong Song is the Co-Founder and General Manager of WestGene Biopharma, and a Professor and Ph.D. Supervisor at Sichuan University. A recipient of China’s National Young Talent Program, she has over 20 years of experience in targeted delivery technologies and RNA therapeutics.

She has pioneered the development of WestGene’s proprietary lipid nanoparticle (LNP) platform and led multiple RNA therapeutic programs into clinical development, including therapeutic cancer vaccines and one of the world’s leading clinical-stage in vivo CAR-T programs. Dr. Song is actively driving the global development of RNA medicines through strategic partnerships and international collaborations, with a focus on translating innovative technologies into impactful therapies. WestGene’s LNP platform has been adopted by biotechnology partners in both China and the United States to support the development of next-generation RNA therapeutics, reflecting the platform’s growing global validation.